Enjoy complimentary customisation on priority with our Enterprise License!
Technavio’s market research analyst predicts the global gonorrhea diagnostics market to grow at a CAGR of more than 9% by 2020. There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.
The growing use of molecular diagnostics for performing gonorrhea tests is a key trend in this market. Some of the new technologies in molecular diagnostics include PCR-based techniques, nucleic acid amplification tests, and DNA nanotechnology. As a result of the high efficiency, variety, accuracy, and reliability of these gonorrhea tests, the growing use of molecular diagnostics is expected to have a positive impact on the growth of the global gonorrhea diagnostics market during the forecast period.
The molecular diagnostics procedure involves the nucleic acid extraction mixtures from gonorrhea cultures that act as a template for the diagnosis. The advancement in molecular biology has played a crucial role in the molecular diagnostics technology positively and has helped in developing a rapid and safe assays for diseases like gonorrhea. Nucleic acid amplification test is the most important molecular diagnostic test involved in the gonorrhea diagnosis.
The Americas accounted for 48% share of the gonorrhea diagnostics market during 2015 and is expected to retain its market dominance during the forecast period. The US is the largest revenue contributor for the sales of gonorrhea diagnosis products. Factors such as the high prevalence of gonorrhea disease, shift to molecular diagnostic tests, and increasing FDA approvals for new products will result in this region’s growth during the forecast period.
This market is highly fragmented and competitive, with the presence of well-diversified international, regional, and local vendors. Local vendors face stiff competition in the market as the international players are increasing their footprints, especially in terms of features and quality. The competition in this market is expected to intensify during the forecast period with an increase in product extensions and technological innovations and an increase in mergers and acquisitions. The lack of skilled laboratory professionals and requirement for high capital investment are major challenges for regional and local players, preventing them from expanding dynamically.
Key vendors in this market are -
The other prominent vendors in the gonorrhea diagnostics market are Agilent Technologies, Alere, Becton Dickinson and Company, Bio-Rad, Cepheid, Diamedix, Kyowa Medex, Lonza, Mackay Life Sciences, Nihon Kohden, Ortho-Clinical Diagnostics, Polymedco, Qiagen, SDIX, Sequenom, Sienco, Sysmex, Takara Bio, ThermoFisher.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Cost analysis
PART 07: Market segmentation by application
PART 08: Geographical segmentation
PART 09: Key leading countries
PART 10: Buying criteria
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
PART 17: Key vendor analysis
PART 18: Appendix
PART 19: Explore Technavio
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.